Low prevalence of gastrointestinal colonization with antimicrobial-resistant bacteria in high risk units in a Canadian tertiary care centre

Canadian Journal of Infectious Diseases

Volumn 7, Issue 5, 1996, Pages 307-312

  Embil, John M ^a   Kabani, Amin ^a   Zhanel, George ^a   Nicolle, Lindsay E ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Infection Control Unit   (Canada)

Author keywords

antimicrobial resistance; dialysis unit; Enterococcus species; intensive care unit; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; METICILLIN; PIPERACILLIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CANADA; CHILD; CITROBACTER; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL INFECTION; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0029825225     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1996/636575     Document Type: Article

References (28)

1. Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064.
2. Swartz MM. Hospital-acquired infections: Diseases with increasingly limited therapies. Proc Natl Acad Sci USA 1994;91:2420-7.
3. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:1065-78.
4. Pechere J-C. Antibiotic resistance is selected primarily in our patients. Infect Control Hosp Epidemiol 1994;15:472-7.
5. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria: A report on the Rockefeller University Workshop. N Engl J Med 1994;330:1247-51.
6. Moreno F, Grota P, Crips C, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in Southern Texas. Clin Infect Dis 1995;21:1234-7.
7. Noble WC, Virani Z, Cree R. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;93:195-8.
8. Hospital Infection Control Practices Advisory Committee (HICPAC). Special report: Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-13.
9. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257:1050-5.
10. Hawkey PM. Resistant bacteria in the normal human flora. J Antimicrob Chemother 1986;18(Suppl):C133-9.
11. Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother 1994;38:409-14.
12. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection. Clin Infect Dis 1995;20:1126-33.
13. Shanahan PMA, Wylie BA, Adrian PV, Koornhof HJ, Thomson CJ, Amyes SGB. The prevalence of antimicrobial resistance in human faecal flora in South Africa. Epidemiol Infect 1993;111:221-8.
14. Levy SB, Marshall B, Schluederberg S, Rowse D, Davis J. High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother 1988;32:1801-6.
15. Facklam RR, Sahm D. Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yoken RH, eds. Manual of Clinical Microbiology, 6th edn. Washington: ASM Press, 1995:308-15.
16. National Committee for Clinical Laboratory Procedures. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, NCCLS Document M7-Aa3, 3rd edn. Villanova: National Committee for Clinical Laboratory Standards, 1993.
17. National Committee for Clinical Laboratory Procedures. Performance standards for antimicrobial disk susceptibility tests, NCCLS Document M2-A5, 5th edn. Villanova: National Committee for Clinical Laboratory Standards, 1993.
18. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical centre. Ann Intern Med 1995;123:250-9.
19. Scriver SR, Canadian Antimicrobial Resistance Study Group, Low DE. Comparative activity of several antimicrobial agents against nosocomial Gram-negative rods isolated across Canada. Can J Infect Dis 1995;6:76-82.
20. Embil J, Ramotar K, Romance L, et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol 1994;15:646-51.
21. Gold WL, Ng J, Goldman H, et al. The epidemiology of methicillin-resistant Staphylococcus aureus in acute care facilities (ACFs): It may not be too late. Clin Invest Med 1994;17:B73. (Abst 433)
22. Ellner PD, Fink DJ, Neu HC, Parry MF. Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates. J Clin Microbiol 1987;25:1668-74.
23. Oster SE, Chirurgi VA, Goldberg AA, Aiken S, McCabe. Ampicillin-resistant enterococcal species in an acute-care hospital. Antimicrob Agents Chemother 1990;34:1821-3.
24. Wiedemann B, Atkinson BA. Susceptibilities to antibiotics: Species incidence and trends. In: Lorian V, ed. Antibiotics in Laboratory Medicine, 3rd edn. Baltimore: Williams and Wilkins, 1991:962-1209.
25. Gordon S, Swenson JM, Hill BC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992;30:23 73-8.
26. Currie BP, Gnass S, Levi MH. A hospital based stool culture survey to detect vancomycin resistant enterococcus (VRE) -Utility and application. Infect Control Hosp Epidemiol 1995;16(Part 2, Suppl):P18. (Abst 15)
27. Cometta A, Calandra T, Bille J, Glauser MP. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 1994;17:1240-1. (Lett)
28. Milatovic D, Braveny I. Development of resistance during antibiotic therapy. Eur J Clin Microbiol 1987;6:234-44